New Open Access Publication by ProteoCure Members

We are pleased to share a new collaborative publication by ProteoCure members, now available in BBA – Molecular Basis of Disease: “Proteome alterations in peripheral immune cells of DLBCL patients and evidence of cancer extracellular vesicles involvement”by Mostafa Ejtehadifar, Sara Zahedi, Paula Gameiro, José Cabeçadas, Manuel S. Rodriguez, Maria Gomes da Silva, Hans Christian Beck,

New Open Access Publication by ProteoCure Members Read More »

PhD Position within Colin Adrain’s group at Queen’s University, Belfast

Overview Diffuse Midline Gliomas (DMGs) are one of the most aggressive and deadly childhood brain cancers. The current treatment, radiotherapy, offers only a short-term life extension (typically only by months). There are no effective long-term therapies, highlighting a major unmet medical need. Recent evidence suggests that radiotherapy may act—at least in part—through a form of

PhD Position within Colin Adrain’s group at Queen’s University, Belfast Read More »

PROTEOCURE WEBINAR

Nicola Burgess-Brown Thursday, March 20th 2025, at 13:00, CET Target 2035: The Goal to Develop a Pharmacological Modulator for Every Human Protein After graduating from university, Nicola moved to SmithKline Beecham where she worked for 1 year before pursuing a PhD in Molecular Microbiology at Nottingham, also sponsored by SB. She then moved to Oxford

PROTEOCURE WEBINAR Read More »

Scroll to Top